Neural thrombin and protease nexin I kinetics after murine peripheral nerve injury

Journal of Neurochemistry

Volumn 67, Issue 5, 1996, Pages 2188-2199

  Smirnova, Irina V ^c   Ma, Jianxin Y ^c   Citron, Bruce A ^c   Ratzlaff, Keith T ^c   Gregory, Eugene J ^c   Akaaboune, Mohammed ^a   Festoff, Barry W ^b  

^a INSERM   (France)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NONE

Author keywords

Nerve injury; Protease nexin I; Protease inhibitor balance; Regeneration; Serpin; Thrombin

Indexed keywords

PROTEASE NEXIN I; PROTHROMBIN; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; THROMBIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; FEMALE; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; MOUSE; NERVE CRUSH; NERVE INJURY; NERVE REGENERATION; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SCHWANN CELL; SCIATIC NERVE;

ANIMALIA; MURINAE;

EID: 0029822135     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.67052188.x     Document Type: Article

References (84)

1. Ausubel F. M., Brent R., Kingston R. E., Moore D. D., Seidman J. G., Smith J. A., and Struhl K. (1987) Current Protocols in Molecular Biology. John Wiley & Sons, New York.
2. Baker J. B., Low D. A., Simmer R. L., and Cunningham D. D. (1980) Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells. Cell 21, 37-45.
3. Bang N. U. and Mattler L. E. (1978) Sensitivity and specificity of plasma serine protease chromogenic substrates. Haemostasis 7, 98-104.
4. Beecher K. L., Andersen T. T., Fenton J. W., and Festoff B. W. (1994) Thrombin receptor peptides induce shape change in neonatal murine astrocytes in culture. J. Neurosci. Res. 37, 108-115.
5. Benzakour O., Kanthou C., Lupu F., Dennehy U., Goodwin C., Scully M. F., Kakkar V. V., and Cooper D. N. (1995) Prothrombin cleavage by human vascular smooth muscle cells: a potential alternative pathway to the coagulation cascade. J. Cell. Biochem. 59, 514-528.
6. Bleuel A. and Monard D. (1995) Regulation of protease nexin-I and angiotensin II receptor subtype 1 expression: inverse relationship in experimental models of nerve injury. J. Neurosci. Res. 42, 562-570.
7. Bleuel A., De Gasparo M., Whitebread S., Püttner I., and Monard D. (1995) Regulation of protease nexin-1 expression in cultured Schwann cells is mediated by angiotensin II receptors. J. Neurosci. 15, 750-761.
8. Bolin L. M., Verity A. N., Silver J. E., Shooter E. M., and Abrams J. S. (1995) Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. J. Neurochem. 64, 850-858.
9. Boutry J. M., Hauw J. J., Gansmuller A., Di Bert N., Pouchelet M., and Baron Van Evercooren A. (1992) Establishment and characterization of a mouse Schwann cell line which produces myelin in vivo. J. Neurosci. Res. 32, 15-26.
10. Brewer G. J. (1995) Exogenous thrombin inhibits neuritogenesis in cultured neuroblastoma cells but not in rat hippocampal neurons. Brain Res. 683, 258-263.
11. Bu G., Maksymovitch E. A., Nerbonne J. M., and Schwartz A. L. (1994) Expression and function of the low density lipoprotein receptor-related protein (LRP) in mammalian central neurons. J. Biol. Chem. 269, 18521-18528.
12. Bush M. S., Reid A. R., and Allt G. (1993) Blood-nerve barrier: ultrastructural and endothelial surface charge alterations following nerve crush. Neuropathol. Appl. Neurobiol. 19, 31-40.
13. Carney D. H., Redin W., and McCroskey L. (1992) Role of high-affinity thrombin receptors in postclotting cellular effects of thrombin. Semin. Thromb. Hemost. 18, 91-103.
14. Carrell R. W. and Travis J. (1985) Alpha 1-antitrypsin and the serpins: variation and countervariation. Trends Biochem. Sci. 10, 20-24.
15. Cavanaugh K. P., Gurwitz D., Cunningham D. D., and Bradshaw R. A. (1990) Reciprocal modulation of astrocyte stellation by thrombin and protease nexin-1. J. Neurochem. 54, 1735-1743.
16. Chirgwin J. M., Przybyla A. E., MacDonald R. J., and Rutter W. J. (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry 18, 5294-5299.
17. Choi B. H., Suzuki M., Kim T., Wagner S. L., and Cunningham D. D. (1990) Protease nexin-1. Localization in the human brain suggests a protective role against extravasated serine proteases. Am. J. Pathol. 137, 741-747.
18. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162, 156-159.
19. Collen D. and Lijnen H. R. (1991) Basic and clinical aspects of flbrinolysis and thrombolysis. [Review] Blood 78, 3114-3124.
20. Conese M., Olson D., and Blasi F. (1994) Protease nexin-1-urokinase complexes are internalized and degraded through a mechanism that requires both urokinase receptor and alpha2-macroglobulin receptor. J. Biol. Chem. 269, 17886-17892.
21. Cunningham D. D., Pulliam L., and Vaughan P. J. (1993) Protease nexin-1 and thrombin: injury-related processes in the brain. Thromb. Haemost. 70, 168-171.
22. Degen S. J., Schaefer L. A., Jamison C. S., Grant S. G., Fitzgibbon J. J., Pai J. A., and Elliott R. W. (1990) Characterization of the cDNA coding for mouse prothrombin and localization of the gene on mouse chromosome 2. DNA Cell Biol. 9, 487-498.
23. Deschepper C. F., Bigornia V., Berens M. E., and Lapointe M. C. (1991) Production of thrombin and antithrombin III by brain and astroglial cell cultures. Brain Res. Mol. Brain Res. 11, 355-358.
24. Dihanich M., Kaser M., Reinhard E., Cunningham D., and Monard D. (1991) Prothrombin mRNA is expressed by cells of the nervous system. Neuron 6, 575-581.
25. Eaton D. L. and Baker J. B. (1983) Phorbol ester and mitogens stimulate human fibroblast secretions of plasmin-activatable plasminogen activator and protease nexin, an antiactivator/antiplasmin. J. Cell Biol. 97, 323-328.
26. Fenton J. W. (1986) Thrombin. Ann. NY Acad. Sci. 485, 5-15.
27. Fenton J. W., Villanueva G. B., Ofosu F. A., and Maraganore J. M. (1991) Thrombin inhibition by hirudin: how hirudin inhibits thrombin. Haemostasis 21 (Suppl. I), 27-31.
28. Festoff B. W. (1990) Serine proteases and their serpin inhibitors in the nervous system: regulation in development and in degenerative and malignant disease, in NATO ASI Series Vol. A191, p. 360. Plenum Press, New York.
29. Festoff B. W., Rao J. S., Maben C., and Hantaï D. (1990α) Plasminogen activators and their inhibitors in the neuromuscular system: I. Developmental regulation of plasminogen activator isoforms during in vitro myogenesis in two cell lines. J. Cell. Physiol. 144, 262-271.
30. Festoff B. W., Rao J. S., Rayford A., and Hantaï D. (1990b) Plasminogen activators and their inhibitors in the neuromuscular system: II. Serpins and serpin: protease complex receptors increase during in vitro myogenesis. J. Cell. Physiol. 144, 272-279.
31. Festoff B. W., Rao J. S., and Hantaï D. (1991) Plasminogen activators and inhibitors in the neuromuscular system: III. The serpin protease nexin I is synthesized by muscle and localized at neuromuscular synapses. J. Cell. Physiol. 147, 76-86.
32. Festoff B. W., Rao J. S., and Chen M. (1992) Protease nexin I, thrombin- and urokinase-inhibiting serpin, concentrated in nor mal human cerebrospinal fluid. Neurology 42, 1361-1366.
33. Festoff B. W., Reddy R. B., VanBecelaere M., Smirnova I., and Chao J. (1994) Activation of serpins and their cognate proteases in muscle after crush injury. J. Cell. Physiol. 159, 11-18.
34. Festoff B. W., Nelson P. G., and Brenneman D. E. (1996) Prevention of activity-dependent neuronal death: vasoactive intestinal polypeptide stimulates astrocytes to secrete the thrombin-inhibiting, neurotrophic serpin, protease nexin I. J. Neurobiol. 30, 255-266.
35. Gloor S., Odink K., Guenther J., Nick H., and Monard D. (1986) A glia-derived neunte promoting factor with protease inhibitory activity belongs to the protease nexins. Cell 47, 687-693.
36. Grabham P. and Cunningham D. D. (1995) Thrombin receptor activation stimulates astrocyte proliferation and reversal of stellation by distinct pathways: involvement of tyrosine phosphorylation. J. Neurochem. 64, 583-591.
37. Grabham P. W., Monard D., Gallimore P. H., and Grand R. J. A. (1991) Modulation of human neunte outgrowth by serine proteases - a comparison of the interaction of thrombin and prothrombin with glia-derived nexin. Eur. J. Neurosci. 3, 663-668.
38. Gurwitz D. and Cunningham D. D. (1988) Thrombin modulates and reverses neuroblastoma neurite outgrowth. Proc. Natl. Acad. Sci. USA 85, 3440-3444.
39. Gurwitz D. and Cunningham D. D. (1990) Neurite outgrowth activity of protease nexin-1 on neuroblastoma cells requires thrombin inhibition. J. Cell. Physiol. 142, 155-162.
40. Gutmann E. (1962) The Denervated Muscle. House of the Czechoslovak Academy of Sciences, Prague.
41. Hansen S. R. and Harker L. A. (1988) Interruption of acute platelet dependent thrombosis by the synthetic antithrombin D-phenyla-lanyl-L-prolyl-L-arginil chloromethyl ketone. Proc. Natl. Acad. Sci. USA 85, 3184-3188.
42. Hantaï D., Rao J. S., and Festoff B. W. (1990) Rapid neural regulation of muscle urokinase-like plasminogen activator as denned by nerve crush. Proc. Natl. Acad. Sci. USA 87, 2926-2930.
43. Ho G. J., Smirnova I. V., Akaaboune M., Hantai D., and Festoff B. W. (1994) Serine proteases and their serpin inhibitors in Alzheimer's disease. Biomed. Pharmacother. 48, 296-304.
44. Jalink K. and Moolenaar W. H. (1992) Thrombin receptor activation causes rapid neural cell rounding and neurite retraction independent of classic second messengers. J. Cell Biol. 118, 411-419.
45. Koj A., Rokita H., Kordula T., Kurdowska A., and Travis J. (1991) Role of cytokines and growth factors in the induced synthesis of proteinase inhibitors belonging to acute phase proteins. Biomed Biochim. Acta 50, 421-425.
46. Laemmli U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
47. Lindahl U., Pejler G., Bogwald J., and Seljelid R. (1989) A prothrombinase complex of mouse peritoneal macrophages. Arch. Biochem. Biophys. 273, 180-188.
48. Liu Y., Fields R. D., Festoff B. W., and Nelson P. G. (1994a) Proteolytic action of thrombin is required for electrical activity-dependent synapse reduction. Proc. Natl. Acad. Sci. USA 91, 10300-10304.
49. Liu Y., Fields R. D., Fitzgerald S., Festoff B. W., and Nelson P. G. (1994b) Proteolytic activity, synapse elimination, and the Hebb synapse. J. Neurobiol. 25, 325-335.
50. Mansuy I. M., van der Putten H., Schmid P., Meins M., Botteri F. M., and Monard D. (1993) Variable and multiple expression of protease nexin-1 during mouse organogenesis and nervous system development. Development 119, 1119-1134.
51. McGrogan M., Kennedy J., Li M., Hsu C., Scott R., Simonson C. W., and Baker J. (1988) Molecular cloning and expression of two forms of human protease nexin 1. Biotechnology 6, 172-177.
52. Meier R., Spreyer P., Ortmann R., Harel A., and Monard D. (1989) Induction of glia-derived nexin after lesion of a peripheral nerve. Nature 342, 548-550.
53. Monard D., Niday E., Limat A., and Solomon F. (1983) Inhibition of protease activity can lead to neunte extension in neuroblastoma cells. Prog. Brain Res. 58, 359-364.
54. Mulligan L. P., Rosenblatt D. E., Toms R., and Johnson D. (1991) Protease nexin-1 activity in cultured Schwann cells. Neurosci. Lett. 128, 42-46.
55. Naldini A., Carney D. H., Bocci V., Klimpel K. D., Asuncion M., Soares L. E., and Klimpel G. R. (1993) Thrombin enhances T cell proliferative responses and cytokine production. Cell. Immunol. 147, 367-377.
56. Nelson R. B. and Siman R. (1990) Thrombin and its inhibitors regulate morphological and biochemical differentiation of astrocytes in vitro. Dev. Brain Res. 54, 93-104.
57. Nitsch C., Scotti A. L., Monard D., Heim C., and Sontag K. H. (1993) The glia-derived protease nexin 1 persists for over 1 year in rat brain areas selectively lesioned by transient global ischaemia. Eur. J. Neurosci. 5, 292-297.
58. Orth K., Madison E. L., Gething M. J., Sambrook J. F., and Herz J. (1992) Complexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type 1 are internalized by means of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. Proc. Natl. Acad. Sci. USA 89, 7422-7426.
59. Pryzdial E. L. G., Bajzar L., and Nesheim M. E. (1995) Prothrombinase components can accelerate tissue plasminogen activator-catalyzed plasminogen activation. J. Biol. Chem. 270, 17871-17877.
60. Rosenblatt D. E., Cotman C. W., Nieto-Sampedro M., Rowe J. W., and Knauer D. J. (1987) Identification of a protease inhibitor produced by astrocytes that is structurally and functionally homologous to human protease nexin-I. Brain Res. 415, 40-48.
61. Rosing J. and Tans G. (1988) Meizothrombin, a major product of factor Xa-catalyzed prothrombin activation. Thromb. Haemost. 60, 355-360.
62. Rychlik W. and Rhoads R. E. (1990) Optimization of the annealing temperature for DNA amplification in vitro. Nucleic Acids Res. 18, 6409-6412.
63. Sambrook J., Fritsch E. F., and Maniatis T. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
64. Schwartz B. S., Levy G. A., Fair D. S., and Edgington T. S. (1982) Murine lymphoid procoagulant activity induced by bacterial lipopolysaccharide and immune complexes is a monocyte prothrombinase. J. Exp. Med. 155, 1464-1479.
65. Scott R. W., Bergman B. L., Bajpai A., Hersh R. T., Rodriguez H., Jones B. N., Barreda C., Watts S., and Baker J. B. (1985) Protease nexin. Properties and a modified purification procedure. J. Biol Chem. 260, 7029-7034.
66. Scotti A. L., Monard D., and Nitsch C. (1994) Re-expression of glia-derived nexin/protease nexin I depends on mode of lesion-induction or terminal degeneration: observations after excitotoxin or 6-hydroxydopamine lesions of rat substantia nigra. J. Neurosci. Res. 37, 155-168.
67. Sekiya F., Usui H., Inoue K., Fukudome K., and Morita T. (1994) Activation of prothrombin by a novel membrane-associated protease. An alternative pathway for thrombin generation independent of the coagulation cascade. J. Biol. Chem. 269, 32441-32445.
68. Smith-Swintosky V. L., Zimmer S., Fenton J. W. II, and Mattson M. P. (1995) Protease nexin-1 and thrombin modulate neuronal Ca2+ homeostasis and sensitivity to glucose deprivation-induced injury. J. Neurosci. 15, 5840-5850.
69. Snider R. M. (1986) Thrombin effects on cultured nerve cells: clinical implications and evidence for a novel mechanism of neuronal activation. Ann. NY Acad. Sci. 485, 310-313.
70. Sommer J., Gloor S. M., Rovelli G. F., Hofsteenge J., Nick H., Meier R., and Monard D. (1987) cDNA sequence coding for a rat glia-derived nexin and its homology to members of the serpin superfamily. Biochemistry 26, 6407-6410.
71. Sower L. E., Froelich C. J., Carney D. H., Fenton J. W. II, and Klimpel G. R. (1995) Thrombin induces IL-6 production in fibroblasts and epithelial cells: evidence for the involvement of the seven-transmembrane domain (STD) receptor for alpha-thrombin. J. Immunol. 155, 895-901.
72. Suidan H. S., Stone S. R., Hemmings B. A., and Monard D. (1992) Thrombin causes neurite retraction in neuronal cells through activation of cell surface receptors. Neuron 8, 363-375.
73. Travis J. and Salvesen G. (1983) Human plasma proteinase inhibitors. Annu. Rev. Biochem. 52, 655-709.
74. Turnell A. S., Brant D. P., Brown G. R., Finney M., Gallimore P. H., Kirk C. J., Pagliuca T. R. V., Campbell C. J., Michell R. H., and Grand R. J. A. (1995) Regulation of neurite outgrowth from differentiated human neuroepithelial cells: a comparison of the activities of prothrombin and thrombin. Biochem. J. 308, 965-973.
75. Vandenabeele P. and Fiers W. (1991) Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated "acute phase response" in the brain? [see comments]. Immunol. Today 12, 217-219.
76. Vassalli J. D., Huarte J., Bosco D., Sappino A. P., Sappino N., Velardi A., Wohlwend A., Erno H., Monard D., and Belin D. (1993) Protease-nexin I as an androgen-dependent secretory product of the murine seminal vesicle. EMBO J. 12, 1871-1878.
77. Vaughan P. J. and Cunningham D. D. (1993) Regulation of protease nexin-1 synthesis and secretion in cultured brain cells by injury-related factors. J. Biol Chem. 268, 3720-3727.
78. Vaughan P. J., Su J., Cotman C. W., and Cunningham D. D. (1994) Protease nexin-1, a potent thrombin inhibitor, is reduced around cerebral blood vessels in Alzheimer's disease. Brain Res. 668, 160-170.
79. Vaughan P. J., Pike C. J., Cotman C. W., and Cunningham D. D. (1995) Thrombin receptor activation protects neurons and astrocytes from cell death produced by environmental insults. J. Neurosci. 15, 5389-5401.
80. Verdière-Sahuqué M., Akaaboune M., Lachkar S., Festoff B. W., Jandrot Peruss M., Garcia L., Barlovatz-Meimon G., and Hantaï D. (1996) Myoblast fusion promotes the appearance of active protease nexin I on human muscle cell surfaces. Exp. Cell Res. 222, 70-76.
81. Wagner S. L., Geddes J. W., Cotman C. W., Lau A. L., Gurwitz D., Isackson P. J., and Cunningham D. D. (1989) Protease nexin-1, an antithrombin with neunte outgrowth activity, is reduced in Alzheimer disease. Proc. Natl. Acad. Sci. USA 86, 8284-8288.
82. Wagner S. L., Van Nostrand W. E., Lau A. L., Farrow J. S., Suzuki M., Bartus R. T., Nguyen A., Cotman C. W., and Cunningham D. D. (1993) Co-distribution of protease nexin-1 and protease nexin-2 in brains of non-human primates. Brain Res. 626, 90-98.
83. Witting J. I., Miller T. M., and Fenton J. W. (1987) Human alpha- and gamma-thrombin specificity with tripeptide p-nitroanilide substrates under physiologically relevant conditions. Thromb. Res. 46, 567-574.
84. Zoubine M. N., Ma J. Y., Smirnova I. V., Citron B. A., and Festoff B. W. (1996) A molecular mechanism for synapse elimination: novel inhibition of locally-generated thrombin delays synapse loss in neonatal mouse muscle. Dev. Biol. (in press).